Bursitis Treatment Market By Type (Anterior Achilles Tendon Bursitis, Posterior Achilles Tendon Bursitis, Hip Bursitis and Others), Treatment Type (Medication, Surgery, Physical Therapy), Drugs (Corticosteroids, Antibiotics, Nonsteroidal Anti-Inflammatory Drugs and Others), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
Market Analysis: Global Bursitis Treatment Market
Global bursitis treatment market is rising gradually with a steady CAGR in the forecast period of 2021-2026. The report contains data of the base year 2018 and historic year 2017. Growing demand of disease specific treatment for bursitis and prevalent cases of family history of this condition are the key drivers for market growth.
Download Full Sample Report Of Bursitis Treatment Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-bursitis-treatment-market
Market Definition: Global Bursitis Treatment Market
Bursitis is severe inflammation of a bursa. It causes tenderness, swelling and pain in the joints. Bursae is small jelly like sacs that are located throughout the body predominantly in around the shoulder, elbow, hip, knee, and heel is act as cushions to help reduce the friction. The patients with bursitis experienced dull pain, tenderness, and stiffness near the affected bursa.
Market Drivers
Vulnerable aging population can enhance the market growth
Rise in prevalence of arthritis and sudden injuries can develop bursitis can also act as a market driver
Accelerates demand of novel therapies is driving the growth of this market
Adoption of unhealthy lifestyles and vigorous aggressive exercise which involved overuse and repeated movements of body can cause bursitis is enhancing the market growth
Market Restraints
Effective treatment is unavailable and unaffordable which can hamper the market growth
Preference over non-conventional therapy over pharmacological therapies is restraint the market growth
Lack of skilled expertise in some middle-income and low-income countries also acting as a challenging factor for the growth of this market
Segmentation: Global Bursitis Treatment Market
By Type
- Anterior Achilles Tendon Bursitis
- Posterior Achilles Tendon Bursitis
- Hip Bursitis
- Others
By Treatment Type
- Medication
- Surgery
- Physical Therapy
By Drugs
- Corticosteroids
- Dexamethasone
- Prednisone
- Antibiotic
- Flucloxacillin
- Erythromycin
- Clarithromycin
- Nonsteroidal Anti-Inflammatory Drugs
- Others
By End Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
By Geography
- North America
- S.
- Canada
- Mexico
- South America
- Brazil
- Rest of South America
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Turkey
- Belgium
- Netherlands
- Switzerland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- South Korea
- India
- Australia
- Singapore
- Thailand
- Malaysia
- Indonesia
- Philippines
- Rest of Asia Pacific
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
Key Developments in the Market:
In September 2017, Vesalius Medical Technologies received the U.S. patent for its Bursitis treatment device and method for the treatment of inflammation of a bursa in a patient's joint. It was filed in the September 2015. The U.S. grants of this patents enables the company to generates the revenue by out-licensed their products to other pharma companies.
Competitive Analysis:
Global bursitis treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global bursitis treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Players:
Few of the major competitors currently working in the global bursitis treatment market are Bone Therapeutics SA, Vesalius Medical Technologies, Endo Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, Pfizer Inc, Mylan N.V., Hikma Pharmaceuticals PLC, Vintage Labs, Jubilant Life Sciences Ltd, Sun Pharmaceutical Industries Limited, Larken Laboratories, Inc, Lannett, WOCKHARDT, Fera Pharmaceuticals and others
Get full details of TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-bursitis-treatment-market
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-bursitis-treatment-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse Related Reports @